Olaf Mundigl
- Cell Biology top 0.5%
- Cellular transport and secretion 15
-
- Neuroscience and Neuropharmacology Research 8
- Molecular Biology top 5%
- Lipid Membrane Structure and Behavior 10
- Glycosylation and Glycoproteins Research 4
- Physiology top 5%
- Developmental Neuroscience top 10%
-
- Monoclonal and Polyclonal Antibodies Research 6
-
- Botulinum Toxin and Related Neurological Disorders 3
-
- Virus-based gene therapy research 2
-
- CAR-T cell therapy research 2
- Co-authors
- Pietro De CamilliLaurie DaniellKohji TakeiPeter S. McPhersonCarol DavidMichela MatteoliKajetan KraszewskiThierry Galli
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Olaf Mundigl
34 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 93
- Cell Biology 1.4k
- Cellular and Molecular Neuroscience 796
- Molecular Biology 1.8k
- Physiology 107
- Developmental Neuroscience 66
Countries citing papers authored by Olaf Mundigl
This map shows the geographic impact of Olaf Mundigl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olaf Mundigl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olaf Mundigl more than expected).
Fields of papers citing papers by Olaf Mundigl
This network shows the impact of papers produced by Olaf Mundigl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olaf Mundigl. The network helps show where Olaf Mundigl may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Olaf Mundigl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 8 | |
| 2 | 2019 | 19 | |
| 3 | 2018 | 19 | |
| 4 | 2015 | 17 | |
| 5 | 2015 | 152 | |
| 6 | 2012 | 24 | |
| 7 | 2011 | 173 | |
| 8 | 2011 | 23 | |
| 9 | 2006 | 14 | |
| 10 | 2002 | 56 | |
| 11 | 2001 | 4 | |
| 12 | 1998 | 88 | |
| 13 | 1996 | 51 | |
| 14 | 1995 | 26 | |
| 15 | 1995 | 62 | |
| 16 | 1995 | 117 | |
| 17 | 1994 | 151 | |
| 18 | 1994 | 43 | |
| 19 | 1994 | 52 | |
| 20 | 1994 | 198 |
About Olaf Mundigl
Olaf Mundigl is a scholar working on Cell Biology, Cellular and Molecular Neuroscience and Molecular Biology, having authored 34 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cellular transport and secretion (15 papers), Lipid Membrane Structure and Behavior (10 papers), Neuroscience and Neuropharmacology Research (8 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Glycosylation and Glycoproteins Research (4 papers), Botulinum Toxin and Related Neurological Disorders (3 papers), Virus-based gene therapy research (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Cell Biology (1.4k citations), Cellular and Molecular Neuroscience (796 citations) and Molecular Biology (1.8k citations). Olaf Mundigl has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Pietro De Camilli, Laurie Daniell, Kohji Takei, Peter S. McPherson, Carol David, Michela Matteoli, Kajetan Kraszewski, Thierry Galli, Tamie J. Chilcote and Claudia Verderio.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.